The authors wish to acknowledge the generous gift of screening compounds from Medicines for Malaria Venture Medicines for Malaria Venture (MMV), PO Box 1826, 20 Route de Pr√©-Bois, 1215 Geneva 15, Switzerland; Pfizer Inc, 235 East 42nd Street, NY, NY 10017, and GSK, GSK House, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. The authors would also like to thank Tim Wells, Paul Fish & Simon Croft for their time and expert advice.